Estudio de la infección por virus del papiloma humano en lesiones bucales y su relación con la carcinogénesis
- A Bascones Martínez 1
- JA García Núñez 1
- MJ Alonso Martín 2
- F Gómez Aguado
- M Roldán Contreras
- F Llanes Méndez 3
- A Picazo Talavera
- MT Comero Pindado
- GC Esparza Gómez 1
- R Cerero Lapiedra 1
-
1
Universidad Complutense de Madrid
info
- 2 A. Patológica Carlos III
- 3 Hospital de San Carlos
Any de publicació: 1996
Volum: 1
Número: 6
Pàgines: 437-445
Tipus: Article
Resum
55 biopsies from the oral cavity were studied, diagnosed as fibroma, papilloma erosive lichen, leucoplakia and carcinoma, appling inmunohistochemical techniques with an anti-HPV policlonal antibody (human pailloma virus), and in situ hybridization with a probe of generic ADN specific of HPV and 3 specific probes of 6/11, 16/18 and 31/33/35 types of HPV. It is also studied the relationship between these viral types and the proliferation degree of the infected epithelium using the MIB 1 antibody (anti Ki-67). Seven biopsies (12,7%) were positive for HPV by inmunohistochemistry, while in 20 biopsies (36,4%) genetic secuencies of HPV were detected with in situ hybridization. By lesions, best result was obtained in papillomas, with 66,7% positive. In benign lesions were detected similar proportions of viral types, while in carcinomas were detected only intermediate and high risk types. It was observed with the MIR 1 antibody that in 84% of non invading lesions practically all the basal layer cells of the epithelium were in cycle. On the contrary, only in two leucoplakias were detected positive MIB 1 cells in the upper third of the epithelium. No significant estatistical correlation has been found among the detected viral type in one lesion and the proportion of MIB 1 positive epithelial cells. We find that in situ hybridization is a more sensitive technique than the inmunohistochemistry for studing these oral lesions and that the HPV can play an etiologic role in benign, premalign and malign lesions. The MIB 1 antibody may be useful in the pronostic value of the premalign lesions.